Hematopoietic stem cell transplantation (HSCT) with a conditioning regimen of busulfan, cyclophosphamide and etoposide for children with acute myelogenous leukemia (AML): A phase I study of the Pediatric Blood and Marrow Transplant Consortium.

Authors

E.S. Sandler
R. Haag
M.J. Coppes
M.M. Mustafa
A. Gamis

Document Type

Journal Article

Publication Date

2000

Journal

Medical and Pediatric Oncology

Volume

35

Issue

4

Inclusive Pages

403-409

Keywords

Pediatrics

APA Citation

Sandler, E., Haag, R., Coppes, M., Mustafa, M., & Gamis, A. (2000). Hematopoietic stem cell transplantation (HSCT) with a conditioning regimen of busulfan, cyclophosphamide and etoposide for children with acute myelogenous leukemia (AML): A phase I study of the Pediatric Blood and Marrow Transplant Consortium.. Medical and Pediatric Oncology, 35 (4). Retrieved from https://hsrc.himmelfarb.gwu.edu/smhs_peds_facpubs/3444